// App-Quantinova.ai

SUN-747 : Diabetc Ketoacidosis Following Asparginase Therapry

Researchers

Presenter

  • Miriam Hinaa Ahmad

Principal Investigators

  • N/A

Medical Centers

  • University of Rochester Medcal Center, Rochester, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Acute lymphoblastic leukemia

  • Diabetic ketoacidosis

  • Acute Leukemia

  • Hyperglycemia

  • Hypertension

  • Prediabetes

  • Peripheral neuropathy

  • Diabetes

  • Obesity

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • Erwinase

  • PEG-asparaginase

  • Daunorubicin

  • Methotrexate

  • Asparaginase

  • Vincristine

  • Cytarabine liposomal

  • Prednisone

  • Intranasal glucagon

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved